Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
93,205
+5,515
+6% +$637K 0.12% 172
2026
Q1
$10.5M Buy
87,690
+4,433
+5% +$581K 0.13% 165
2025
Q4
$11.3M Buy
83,257
+7,247
+10% +$1.04M 0.16% 141
2025
Q3
$11.2M Sell
76,010
-23,232
-23% -$3.22M 0.14% 161
2025
Q2
$12.8M Buy
99,242
+26,265
+36% +$3.18M 0.17% 127
2025
Q1
$8.72M Sell
72,977
-546
-0.7% -$67.7K 0.13% 174
2024
Q4
$8.53M Buy
73,523
+529
+0.7% +$66.9K 0.13% 167
2024
Q3
$9.86M Sell
72,994
-1,199
-2% -$160K 0.15% 146
2024
Q2
$10.1M Buy
74,193
+547
+0.7% +$74.4K 0.16% 129
2024
Q1
$9.52M Sell
73,646
-1,503
-2% -$182K 0.16% 142
2023
Q4
$8.59M Sell
75,149
-332
-0.4% -$33.1K 0.16% 147
2023
Q3
$6.87M Sell
75,481
-83
-0.1% -$8.56K 0.14% 167
2023
Q2
$8.51M Buy
75,564
+1,098
+1% +$116K 0.17% 131
2023
Q1
$7.8M Buy
74,466
+92
+0.1% +$9.61K 0.17% 138
2022
Q4
$8.22M Sell
74,374
-1,612
-2% -$169K 0.19% 125
2022
Q3
$6.64M Sell
75,986
-224
-0.3% -$20.4K 0.16% 152
2022
Q2
$5.96M Buy
76,210
+146
+0.2% +$12.1K 0.13% 185
2022
Q1
$6.49M Buy
76,064
+1,094
+1% +$105K 0.12% 209
2021
Q4
$8.99M Sell
74,970
-27,728
-27% -$3.44M 0.16% 129
2021
Q3
$12.7M Sell
102,698
-34,510
-25% -$4.44M 0.24% 88
2021
Q2
$16.5M Buy
137,208
+36,823
+37% +$4.21M 0.3% 70
2021
Q1
$10.6M Buy
100,385
+19,087
+23% +$1.94M 0.21% 107
2020
Q4
$8.28M Sell
81,298
-4,455
-5% -$419K 0.17% 128
2020
Q3
$7.21M Sell
85,753
-4,573
-5% -$356K 0.18% 119
2020
Q2
$5.87M Sell
90,326
-10,405
-10% -$687K 0.15% 135
2020
Q1
$6.56M Sell
100,731
-9,576
-9% -$755K 0.2% 106
2019
Q4
$8.69M Buy
110,307
+1,138
+1% +$88.6K 0.22% 96
2019
Q3
$8.69M Sell
109,169
-4,668
-4% -$367K 0.24% 90
2019
Q2
$9.52M Sell
113,837
-627
-0.5% -$50K 0.26% 81
2019
Q1
$9.05M Sell
114,464
-1,067
-0.9% -$77.9K 0.24% 87
2018
Q4
$7.71M Sell
115,531
-18,778
-14% -$1.3M 0.24% 94
2018
Q3
$10.7M Buy
134,309
+74
+0.1% +$5.53K 0.27% 81
2018
Q2
$9.04M Buy
134,235
+1,430
+1% +$104K 0.25% 90
2018
Q1
$10.2M Sell
132,805
-8,261
-6% -$611K 0.26% 87
2017
Q4
$9.62M Sell
141,066
-3,330
-2% -$221K 0.25% 86
2017
Q3
$9.04M Sell
144,396
-6,980
-5% -$417K 0.24% 88
2017
Q2
$8.39M Buy
151,376
+3,507
+2% +$183K 0.23% 100
2017
Q1
$7.43M Sell
147,869
-6,353
-4% -$310K 0.21% 110
2016
Q4
$7.64M Sell
154,222
-4,335
-3% -$220K 0.22% 104
2016
Q3
$8.32M Buy
158,557
+4,924
+3% +$241K 0.24% 93
2016
Q2
$6.86M Sell
153,633
-2,759
-2% -$120K 0.2% 107
2016
Q1
$6.4M Sell
156,392
-2,663
-2% -$98.1K 0.19% 115
2015
Q4
$5.8M Buy
159,055
+247
+0.2% +$8.93K 0.17% 131
2015
Q3
$5.22M Buy
158,808
+9,475
+6% +$319K 0.16% 152
2015
Q2
$5.54M Buy
149,333
+13,584
+10% +$494K 0.15% 155
2015
Q1
$4.75M Buy
135,749
+12,237
+10% +$432K 0.13% 186
2014
Q4
$4.7M Buy
123,512
+23,092
+23% +$845K 0.14% 183
2014
Q3
$3.56M Buy
100,420
+22,859
+29% +$849K 0.11% 233
2014
Q2
$3.03M Buy
77,561
+9,611
+14% +$359K 0.09% 258
2014
Q1
$2.47M Buy
67,950
+900
+1% +$32.8K 0.07% 328
2013
Q4
$2.32M Sell
67,050
-430
-0.6% -$13.8K 0.07% 323
2013
Q3
$1.88M Buy
67,480
+29,239
+76% +$780K 0.07% 335
2013
Q2
$1.03M Buy
+38,241
New +$1.06M 0.04% 506

Other funds holding XYL

Oppenheimer & Co's XYL Position: Q2 2026 in Review

Oppenheimer & Co increased its Xylem (XYL) stake by 6.3% in Q2 2026, buying an estimated $637K and bringing the position to 93,205 shares worth $11M. The position accounts for 0.12% of the portfolio, ranked #172.

Oppenheimer & Co first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.5M in Q2 2021. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Oppenheimer & Co held 93,205 shares of Xylem worth $11M as of Q2 2026.
  • Oppenheimer & Co bought 5,515 Xylem shares in Q2 2026, an estimated $637K.
  • Xylem made up 0.12% of Oppenheimer & Co's portfolio in Q2 2026, its #172 holding.
  • Oppenheimer & Co first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Oppenheimer & Co's Xylem position peaked at $16.5M in Q2 2021.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.